In the latest Cancer Matters podcast, Dr Bill Nelson talks with Dr Janis Taube and Dr Alex Szalay about AstroPath, a new platform that combines astronomy with pathology to identify predictive biomarkers for cancer immunotherapy.
Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by Dung Le. Le is now testing new iterations of the therapy to see if she can help more patients. A new drug cocktail adds immunotherapy and a PARP inhibitor to […]
Nov 19, 2020 No comments
Researchers at the Johns Hopkins Kimmel Cancer Center are studying the immune system to find what does and doesn't work to better fight soft tissue & bone cancer. “The basis of successful immunotherapy lies in the ability of the immune system to recognize cancer as foreign and attack, and is dependent on genetics, host and […]
Jun 25, 2020 No comments
Clement Okoh is a cancer survivor, author, entrepreneur….and proud grandfather. Cancer Matters is sharing book excerpts of his personal journey, “OSONDU,", an inspiring story of hope. Photo: Me with RN's Michaella Iacoboni and Manny Bravo. Read part 1 here: PART 1, PART 2 -- OSONDU – Agency, Hope and Survival (part 3) It’s nearly impossible […]
Jan 13, 2020 No comments
In this Cancer Matters podcast, Dr Bill Nelson talks with Dr Julie Brahmer about the advances made in treating patients with lung cancer, smoking cessation and lung cancer screening.
Dec 26, 2019 No comments
In the next On Target podcast, Dr Akila Viswanathan speaks with Dr Lawrence Kleinberg about the treatment of brain cancer and engaging the immune system to combat tumors.
Oct 22, 2019 No comments
Janice Paulshock is a busy woman. The 58-year-old resident of Harford County, a Maryland suburb, works full-time; is a committed mother and grandmother; runs to keep in shape; participates in charity bike rides to raise money for multiple sclerosis, from which her husband suffers; and volunteers to support current patients and medical students at Johns […]
Aug 9, 2019 6 comments
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]
Jan 28, 2019 No comments
Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention […]
Nov 16, 2018 No comments
Dr Bill Nelson speaks with Dr Drew Pardoll, the Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, about the progress being made in empowering patient's own immune system to combat their cancer.
Aug 3, 2018 2 comments